大博医疗(002901.SZ)发布上半年业绩，归母净利润2.44亿元，增长76.69%

Group 1 - The core viewpoint of the article is that Dabo Medical (002901.SZ) has shown significant growth in its financial performance for the first half of 2025, with notable increases in both revenue and net profit [1] - The company's operating revenue reached 1.21 billion yuan, representing a year-on-year growth of 25.55% [1] - The net profit attributable to shareholders of the listed company was 244 million yuan, reflecting a year-on-year increase of 76.69% [1] Group 2 - The net profit attributable to shareholders after deducting non-recurring gains and losses was 223 million yuan, which is an increase of 82.64% year-on-year [1] - The basic earnings per share for the company stood at 0.6007 yuan [1]